Skip to main content

GOP Senator Voices Support For Marijuana Banking Bill He’s Yet To Cosponsor

Andrew Yang says that decriminalizing opioids and legalizing “certain drugs” is one tool that can be used to undermine international drug cartels and reduce violence associated with the illicit drug trade.

In an interview published last week, the 2020 Democratic presidential candidate was pressed on his plan to address cartels operating below the U.S.’s Southern border, and he said that “one approach we could take that would change the resources available to the cartels [is to] explore the legalization of certain drugs.”

“I’m open to looking at legalizing different drugs that are not just fueling the cartel but also in some cases would frankly be an upgrade over the opiates that many Americans are currently getting addicted to,” he said.

While Yang used the term “legalization,” which would imply some kind of regulatory scheme for controlled substances, he later clarified this his proposal for opioids would not involve making drugs like heroin commercially available. Rather, it would focus on removing the threat of jail time for simple possession and diverting people with substance misuse issues to treatment.

On the other hand, he told the H3 Podcast that legalizing marijuana “is the easy one” and also said his agenda would involve reforming federal laws around psilocybin mushrooms and other psychedelics, despite the fact that those substances are “not a huge economic driver of the cartels.”

Earlier this month, in a tweet, Yang said that he wants to make psychedelic mushrooms “more freely available,” especially for military veterans.

In the new podcast interview, Yang called decriminalizing opioids “the most dramatic” aspect of his drug policy plan.

“I’m actually looking to decriminalize opiates for personal use because we have eight Americans dying of drug overdoses every hour in this country,” he said. We’ve essentially initiated this massive opiate addiction plague, and it was a disease of capitalism. It started off [with] Purdue Pharma prescribing OxyContin and saying it’s a non-addictive wonder drug.”

“What happened was OxyContin addiction morphed into fentanyl and heroin and then a lot of that is what’s getting trafficked now,” he said. “We’ve created this nation of addicts, and they’ve actually found that OxyContin is now harder to get ahold off than the illegal stuff so you have this massive drug trade and it’s driving the resources.”

“What I’m proposing is we legalize opiates for personal use, which means if we catch you with the drugs, you get the drugs taken away from you but we don’t send you to jail, we send you to treatment and counseling and then we set up safe injection sites and safe consumption sites in the U.S. that are controversial, but they’ve been proven to work and save lives. If you did this, you could bring in some of this drug use out of the shadows and then get your user base down and then get the economic resources that are going to the cartels down.”

Asked where individuals would obtain illicit drugs under his proposed decriminalization model, Yang acknowledged that the source wouldn’t change but that the goal would be to decrease demand and resulting rates of substance misuse and overdoses.

“Right now they’re buying it from dealers, and then in my new world, they’d still be buying it from dealers. The dealers still go to jail. It’s just that the individual users don’t get sent to jail with the dealer,” he said. “You have to try to attack demand.”

Several Democratic presidential candidates have broadened their drug policy platform to include decriminalization of drugs beyond cannabis. South Bend, Indiana Mayor Pete Buttigieg and Rep. Tulsi Gabbard (D-HI), for example, have said that personal possession of any drug should not result in incarceration.

Yang’s perspective on maintaining criminalization for those selling the drugs has recently been disputed by the advocacy group the Drug Policy Alliance, which issued a report earlier this month arguing that taking such an approach makes illicit substances cheaper and more dangerous, and it also ignores the reality that many involved in drug selling suffer from addiction as well.

In any case, the candidate went on to again characterize the opioid crisis as a problem created by profit-minded drug companies.

“This is a disease where the government essentially turned a blind eye and let a drug company kill tens of thousands of Americans for profit, and now we’re left with the mess and the bill and it’s a human toll,” he said. “And it’s fueling what’s happening with the drug cartels because this is the majority of their business.”

Marijuana On The 2020 Ballot: These States Could Vote

Photo courtesy of YouTube/H3 Podcast.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Original Article Source: https://www.marijuanamoment.net/gop-senator-voices-support-for-marijuana-banking-bill-hes-yet-to-cosponsor/

Comments

Popular posts from this blog

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

A Dozen US Governors Ask Congressional Leaders To Back Federal Marijuana Reform

A bipartisan coalition of 12 governors from states that have legalized medical or recreational cannabis  sent a letter to congressional leaders, asking for their support in getting a major marijuana reform bill through the U.S. House and Senate. The governors of California, Colorado, Maryland, Massachusetts, Nevada, New York, North Dakota, Oregon, Pennsylvania, Utah, Vermont and Washington state are backing  the STATES Act  – which would codify in federal law that marijuana regulations are to be left to the states instead of the federal government – while also seeking protections on banking and tax issues for the MJ industry. “The STATES Act is not about whether marijuana should be legal or illegal; it is about respecting the authority of states to act, lead and respond to the evolving needs and attitudes of their citizens,” the governors wrote. The letter also expressed support for the SAFE Banking Act , which was approved in March by a House committee. Tha...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...